338 related articles for article (PubMed ID: 34638371)
1. Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias.
Duchmann M; Laplane L; Itzykson R
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638371
[TBL] [Abstract][Full Text] [Related]
2. Emergence of heterogeneity in acute leukemias.
Stiehl T; Lutz C; Marciniak-Czochra A
Biol Direct; 2016 Oct; 11(1):51. PubMed ID: 27733173
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the Genetic and Non-Genetic Heterogeneity of Acute Myeloid Leukemia Using Next-Generation Sequencing and In Vivo Models.
Desai RH; Zandvakili N; Bohlander SK
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565315
[TBL] [Abstract][Full Text] [Related]
4. Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia.
Itzykson R; Duployez N; Fasan A; Decool G; Marceau-Renaut A; Meggendorfer M; Jourdan E; Petit A; Lapillonne H; Micol JB; Cornillet-Lefebvre P; Ifrah N; Leverger G; Dombret H; Boissel N; Haferlach T; Preudhomme C
Blood; 2018 Jul; 132(2):187-196. PubMed ID: 29692343
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Sequencing: Ariadne's Thread in the Maze of Acute Myeloid Leukemia.
Redavid I; Conserva MR; Anelli L; Zagaria A; Specchia G; Musto P; Albano F
Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454044
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic pathways in acute myeloid leukemias.
Cucuianu A
Rom J Physiol; 2004; 41(1-2):109-18. PubMed ID: 15984661
[TBL] [Abstract][Full Text] [Related]
7. [Application and clinical study of clonal heterogeneity analysis in acute myeloid leukemia].
Lyu XD; Guo Z; Li YW; Hu JY; Fan RH; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):483-489. PubMed ID: 32654462
[No Abstract] [Full Text] [Related]
8. Dominant and opportunistic leukemic clones: proposal for a pathogenesis-oriented classification in acute myeloid leukemia.
Cucuianu A
Med Hypotheses; 2005; 65(1):107-13. PubMed ID: 15893127
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.
Carr RM; Patnaik MM
Curr Opin Hematol; 2020 Jan; 27(1):2-10. PubMed ID: 31688455
[TBL] [Abstract][Full Text] [Related]
10. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.
Chao MP; Gentles AJ; Chatterjee S; Lan F; Reinisch A; Corces MR; Xavy S; Shen J; Haag D; Chanda S; Sinha R; Morganti RM; Nishimura T; Ameen M; Wu H; Wernig M; Wu JC; Majeti R
Cell Stem Cell; 2017 Mar; 20(3):329-344.e7. PubMed ID: 28089908
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic heterogeneity in acute myeloid leukemia.
Li S; Mason CE; Melnick A
Curr Opin Genet Dev; 2016 Feb; 36():100-6. PubMed ID: 27162099
[TBL] [Abstract][Full Text] [Related]
13. Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia.
Paguirigan AL; Smith J; Meshinchi S; Carroll M; Maley C; Radich JP
Sci Transl Med; 2015 Apr; 7(281):281re2. PubMed ID: 25834112
[TBL] [Abstract][Full Text] [Related]
14. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
15. An evolutionary perspective on chronic myelomonocytic leukemia.
Itzykson R; Solary E
Leukemia; 2013 Jul; 27(7):1441-50. PubMed ID: 23558522
[TBL] [Abstract][Full Text] [Related]
16. Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy.
Castelli G; Pelosi E; Testa U
Onco Targets Ther; 2018; 11():131-155. PubMed ID: 29343972
[TBL] [Abstract][Full Text] [Related]
17. Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing.
Chen A; Hu S; Wang QF
Blood Sci; 2019 Aug; 1(1):73-76. PubMed ID: 35402804
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of mutations and clonal evolution patterns in a cohort of patients with cytogenetically normal acute myeloid leukemia.
Mat Yusoff Y; Ahid F; Abu Seman Z; Abdullah J; Kamaluddin NR; Esa E; Zakaria Z
Mol Cytogenet; 2021 Sep; 14(1):45. PubMed ID: 34560908
[TBL] [Abstract][Full Text] [Related]
19. Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia.
Bochtler T; Stölzel F; Heilig CE; Kunz C; Mohr B; Jauch A; Janssen JW; Kramer M; Benner A; Bornhäuser M; Ho AD; Ehninger G; Schaich M; Krämer A
J Clin Oncol; 2013 Nov; 31(31):3898-905. PubMed ID: 24062393
[TBL] [Abstract][Full Text] [Related]
20. Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia.
Bochtler T; Fröhling S; Krämer A
Leukemia; 2015 Jun; 29(6):1243-52. PubMed ID: 25673237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
